Practical strategy for optimizing the timing of anti-tumor necrosis factor-α therapy in Crohn disease: A nationwide population-based study.

Medicine
Min Seob KwakHun Hee Lee

Abstract

There is little consensus on the optimal timing of anti-tumor necrosis factor (anti-TNF) therapy to decrease the rates of hospitalization and surgery in Crohn disease (CD). We aimed to assess the real-world outcomes of anti-TNF therapy and estimate the optimal timing of anti-TNF therapy in Korean patients with CD.Claims data were extracted from the Korean Health Insurance Review and Assessment Service database. Incident patients diagnosed with CD between 2009 and 2016, with at least 1 anti-TNF drug prescription, and with follow-up duration > 6 months were stratified according to the number of relapses prior to initiation of anti-TNF therapy: groups A (≤1 relapse), B (2 relapses), C (3 relapses), and D (≥4 relapses). The cumulative survival curves free from emergency hospitalization (EH) and surgery were compared across groups.Among the 2173 patients analyzed, the best and worst prognoses were noted in groups A and D, respectively. The incidences of EH and surgery decreased significantly as the use of anti-TNF agents increased. The 5-year rate of hospitalization was significantly lower in group A than in groups C and D (P = .004 and .020, respectively), but similar between groups A and B. The 5-year rate of surgery was lower in ...Continue Reading

References

Dec 11, 2002·JAMA : the Journal of the American Medical Association·R Brian HaynesAmit X Garg
Aug 13, 2004·Gut·M J CarterUNKNOWN IBD Section, British Society of Gastroenterology
Dec 25, 2004·Journal of Clinical Epidemiology·Vijaya SundararajanWilliam A Ghali
Jan 13, 2006·The American Journal of Gastroenterology·Charles N Bernstein, Alice Nabalamba
Apr 27, 2007·The American Journal of Gastroenterology·Teresa Longobardi, Charles N Bernstein
Sep 11, 2007·Digestive Diseases·Filip BaertErika Angelucci
Sep 11, 2007·Inflammatory Bowel Diseases·Geoffrey C NguyenSteven R Brant
Oct 13, 2009·Gastroenterology·Filip BaertUNKNOWN North-Holland Gut Club
Dec 10, 2009·Inflammatory Bowel Diseases·Dídia Bismara Cury, Alan C Moss
Jan 14, 2010·The American Journal of Gastroenterology·Asher KornbluthUNKNOWN Practice Parameters Committee of the American College of Gastroenterology
Jun 30, 2010·Annals of Surgery·Douglas W Jones, Samuel R G Finlayson
Apr 6, 2011·Gut·Craig MowatUNKNOWN IBD Section of the British Society of Gastroenterology
Apr 13, 2011·Inflammatory Bowel Diseases·Walter ReinischBruce E Sands
Sep 15, 2012·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Monia MarchettiGino R Corazza
Apr 20, 2013·Inflammatory Bowel Diseases·Leyla J GhaziRaymond K Cross
Mar 5, 2014·Journal of Neurointerventional Surgery·Joshua A HirschLaxmaiah Manchikanti
Aug 20, 2015·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Cristina B GeltzeilerVassiliki L Tsikitis
Nov 29, 2015·Journal of Crohn's & Colitis·Marcus HarbordUNKNOWN European Crohn’s and Colitis Organisation
Feb 28, 2017·Intestinal research·Jae Jun ParkUNKNOWN IBD Study Group of the Korean Association for the Study of Intestinal Diseases
Nov 1, 2017·The American Journal of Gastroenterology·Christopher MaGilaad G Kaplan
Feb 6, 2018·Journal of Crohn's & Colitis·Daniël R HoekmanUNKNOWN BIRD (Belgian Inflammatory Bowel Disease Research and Development) Group; North-Holland Gut Club

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Software Mentioned

R

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
Laura E TargownikCharles N Bernstein
Clinical Rheumatology
Omer Nuri Pamuk, Salim Dönmez
© 2021 Meta ULC. All rights reserved